Profile |  Business Strategy |  Competitive Positioning |  History |  People |  Facilities

Business Strategy

Develop superior competence and technologies for the engineering of human recombinant antibodies useful for in vivo detection and therapeutic intervention.




Generate a fully human antibody-based product pipeline through in-house programs and strategic collaborations with pharma and biotech companies.




Acquire market access and complimentary technologies through partnerships with leading biopharmaceutical companies and research institutions.